Hikma Farmaceutica Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HIKMA FARMACEUTICA, and what generic and branded alternatives to HIKMA FARMACEUTICA drugs are available?
HIKMA FARMACEUTICA has thirty-eight approved drugs.
Drugs and US Patents for Hikma Farmaceutica
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma Farmaceutica | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065047-001 | Sep 18, 2001 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hikma Farmaceutica | MILRINONE LACTATE IN PLASTIC CONTAINER | milrinone lactate | INJECTABLE;INJECTION | 090038-002 | Jan 21, 2010 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hikma Farmaceutica | ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE | ondansetron hydrochloride | INJECTABLE;INJECTION | 076780-001 | Dec 26, 2006 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.